UnitedHealth Group and CVS Health are asking that Federal Trade Commission Chairwoman Lina Khan and two other commissioners recuse themselves from a lawsuit accusing the nation’s largest pharmacy benefit managers of inflating insulin prices, CNBC reported Oct. 9.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis
